CG
HARP

Cutler Group’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Cutler Group’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-60
Closed – – 5004
2022
Q4 		$0 Buy
+60
New +$505 ﹤0.01% 5512
2022
Q2 		– Sell
-273
Closed -$13K – 5930
2022
Q1 		$13K Sell
273
-30
-10% -$1.55K ﹤0.01% 3434
2021
Q4 		$22K Buy
303
+293
+2,930% +$20K ﹤0.01% 3062
2021
Q3 		$0 Buy
+10
New +$1K ﹤0.01% 6594

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Cutler Group's HARP Position: Q1 2023 in Review

Cutler Group sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2023, closing a stake of 60 shares.

Cutler Group first reported a position in HARP in Q3 2021 and held it in 4 quarters. The position peaked at $22K in Q4 2021. 46 funds tracked by Wall St. Rank hold HARP as of Q1 2023.

  • Cutler Group reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 60 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2023.
  • Cutler Group first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • Cutler Group's Harpoon Therapeutics, Inc. Common Stock position peaked at $22K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.